Elizabeth Marianne Swift, CNM | |
190 Riverview St, Suite 2, Franklin, NC 28734-2612 | |
(828) 349-8288 | |
(828) 349-8289 |
Full Name | Elizabeth Marianne Swift |
---|---|
Gender | Female |
Speciality | Advanced Practice Midwife |
Location | 190 Riverview St, Franklin, North Carolina |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1548294523 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367A00000X | Advanced Practice Midwife | 157751 (North Carolina) | Primary |
Mailing Address | Practice Location Address |
---|---|
Elizabeth Marianne Swift, CNM Po Box 1209, Franklin, NC 28744-0569 Ph: (828) 213-1500 | Elizabeth Marianne Swift, CNM 190 Riverview St, Suite 2, Franklin, NC 28734-2612 Ph: (828) 349-8288 |
News Archive
A world-first breakthrough to treat high blood pressure has been successfully trialled in Melbourne.
In the same week that the U.S. surgeon general issued a 101-page report about the dangers of skin cancer, researchers at Montana State University published a paper breaking new ground on how DNA - the genetic code in every cell - responds when exposed to ultraviolet (UV) light.
Cloud Pharmaceuticals, Inc., an Artificial Intelligence-driven drug design and development company, announced today they have entered into drug discovery collaboration with GlaxoSmithKline (GSK). Cloud will design novel small-molecule agents to GSK specified targets.
Reflectance Medical, a commercial-stage company focused on the development of physiologic sensors to non-invasively and continuously assess patient metabolic status, announced today that it has received FDA 510(k) clearance for its initial product, the CareGuide Oximeter.
Surgery Center Holdings Inc. ("Surgery Partners" or "The Company"), a portfolio company of H.I.G. Capital, LLC ("H.I.G."), and Symbion Holdings Corporation ("Symbion"), a portfolio company of Crestview Partners, have announced that they have entered into a definitive merger agreement under which Surgery Partners will acquire 100% of the stock of Symbion for a total purchase price of $792 million.
› Verified 6 days ago